Page 3 - Biopharmaceuticals Business Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WAINUA™ (eplontersen) granted regulatory approval in the U S for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis

/PRNewswire/ Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved Ionis and.

United statesMichaelj polydefkisIsabelle lousadaJournal of the american medical associationIonis pharmaceuticalsPrnewswire ionis pharmaceuticals incDrug administrationJohns hopkins university school of medicineExchange commissionIonis pharmaceuticals incAmyloidosis research consortiumNeuropathy impairment scoreNorfolk qualityLife questionnaire diabetic neuropathyAmerican medical associationJohns hopkins university school

WAINUA™ (eplontersen) Granted First-Ever Regulatory Approval in the US for the Treatment of Adults With Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

WAINUA™ (eplontersen) Granted First-Ever Regulatory Approval in the US for the Treatment of Adults With Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomIsabelle lousadaBrendan mcevoyMichaelj polydefkisChelsea tresslerEuropean parliamentCommission implementing decisionColumbia university irving medical centerIonis pharmaceuticalsDrug administrationAmyloidosis research consortiumEuropean commissionJournal of the american medical associationNeuropathy impairment scoreNorfolk quality

WAINUAtm (eplontersen) Granted First-Ever Regulatory Approval in the US for the Treatment of Adults With Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

WAINUAtm (eplontersen) Granted First-Ever Regulatory Approval in the US for the Treatment of Adults With Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesMichaelj polydefkisIsabelle lousadaColumbia university irving medical centerProduct serviceAmyloidosis research consortiumCommission implementing decisionJournal of the american medical associationIonis pharmaceuticalsEuropean commissionEuropean parliamentDrug administrationGranted first ever regulatory approvalAdults with polyneuropathyHereditary transthyretin mediated

Ionis Pharmaceuticals (IONS) Announces FDA Approval of WAINUA

Ionis Pharmaceuticals (IONS) Announces FDA Approval of WAINUA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichaelj polydefkisIsabelle lousadaAmyloidosis research consortiumJohns hopkins university school of medicineJournal of the american medical associationDrug administrationIonis pharmaceuticals incIonis pharmaceuticalsNeuropathy impairment scoreNorfolk qualityLife questionnaire diabetic neuropathyAmerican medical associationJohns hopkins university schoolBiopharmaceuticals business unitOrphan drug designation

AstraZeneca s Wainua receives FDA approval in the US

AstraZeneca's Wainua receives FDA approval in the US

United statesIsabelle lousadaMichaelj polydefkisColumbia university irving medical centerEuropean parliamentDrug administrationJournal of the american medical associationCommission implementing decisionAmyloidosis research consortiumIonis pharmaceuticalsEuropean commissionNeuropathy impairment scoreNorfolk qualityLife questionnaire diabetic neuropathyAmerican medical associationJohns hopkins university school